Clinical Trial Update: Effects of Nicorandil on Microvascular Dysfunction in Patients With STEMI Undergoing Primary PCI [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating nicorandil for microvascular dysfunction in patients with ST-segment elevation myocardial infarction undergoing primary PCI…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-segment Elevation Myocardial Infarction

Drugs mentioned

• Nicorandil (nicorandil)

Snippet

Sponsor: China National Center for Cardiovascular Diseases | Conditions: STEMI - ST-segment Elevation Myocardial Infarction | Phase 4 | Status: NOT_YET_RECRUITING